In normal OEM-related manufacturing, you maybe have 20-30% of the assembly plant automated. Tesla does that with 80-90%. In the beginning of my career, I started in manufacturing. After the boy in white part, the paint job is more or less 80-90% automated. Of course, they have thought about automation: how they could do it and how it would make sense to map the assembly plant with that high automation rate, let’s say by comparison to a paint job. The result of those kinds of studies was always that it was not worth doing, you lose flexibility. Elon said “I’m not interested in those experiences, I have my own model and I will go in that direction.” I think that was the big failure.
I don’t think so, because the conclusion that came out of that was that he is reengineering the assembly plant. You’ve seen the pictures, he is still doing a lot of handworking. He is still reengineering his assembly plant with a clear focus to throw out a lot of the robots that he put in with that dream to make that step forward in automation.
There’s been issue with the paint work and some other issues with the body in white. Is there any part of the process that you think doesn’t work for this level of automation?
The problem with the paint was perhaps related to the fact that the paint job itself wasn’t stable enough and the quality control wasn’t good enough in order to reduce the running rate. Additionally, he is not willing to have higher running rates, 10-20% running rates, which is more or less a given. in most of the OEMs, you have some kind of reduced running rate, not 100%, maybe 85-90%, which is quite remarkable. He was not prepared to do so. Where customers complained about the quality issues, those paint problems, were more related to that.
The assembly plant with the highly automated equipment means that he couldn’t put through the capacity. A failure here, a failure there and this robot with some kind of a mismatch or something like that, that reduces their running rate and the efficiency in the assembly plant.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities.
© 2024 IP 1 Ltd. All rights reserved.